'Plasminogen activators' presentation slideshows

Plasminogen activators - PowerPoint PPT Presentation

STEMI MANAGEMENT

STEMI MANAGEMENT

STEMI MANAGEMENT. Definition Criteria.. e/o myocardial necrosis in a clinical setting consistent with myocardial ischaemia.

★ ★ ★ ★ ★

1.16k views • 70 slides
PIH/Preeclampsia

PIH/Preeclampsia

PIH/Preeclampsia. Jeff Katz, MD. Gestational Hypertension. Systolic > 140 mmHg Diastolic > 90 mmHg Occurs after 20 weeks in gestation Returns to baseline postpartum. Preeclampsia. Gestational HTN + Proteinuria Occurs after 20 weeks in gestation Returns to baseline postpartum Dx:

★ ★ ★ ★ ★

769 views • 40 slides
THROMBOLYTIC DRUGS (Fibrinolytic drugs) By Prof. Hanan Hagar Dr. Ishfaq Bukhari

THROMBOLYTIC DRUGS (Fibrinolytic drugs) By Prof. Hanan Hagar Dr. Ishfaq Bukhari

THROMBOLYTIC DRUGS (Fibrinolytic drugs) By Prof. Hanan Hagar Dr. Ishfaq Bukhari. OBJECTIVES. To know mechanism of action of thrombolytic therapy. To differentiate between different types of thrombolytic drugs. To describe indications, side effects and contraindications of thrombolytic drugs.

★ ★ ★ ★ ★

531 views • 34 slides
FIBRINOLSIS SYSTEM

FIBRINOLSIS SYSTEM

FIBRINOLSIS SYSTEM. DR MOHAMMED SAIEMALDAHR Faculty of Applied Medical Sciences Medical Technology Dep. FIBRINOLSIS SYSTEM. Fibrinolysis System in Homeostasis

★ ★ ★ ★ ★

576 views • 24 slides
FIBRINOLSIS SYSTEM

FIBRINOLSIS SYSTEM

FIBRINOLSIS SYSTEM. Ahmad Shihada Silmi Msc, FIBMS IUG Faculty of Sciences Medical Technology Dep. FIBRINOLSIS SYSTEM. Fibrinolysis System in Homeostasis

★ ★ ★ ★ ★

491 views • 24 slides
THROMBOLYSIS Alteplase: Pharmacodynamics and Pharmacokinetics

THROMBOLYSIS Alteplase: Pharmacodynamics and Pharmacokinetics

THROMBOLYSIS Alteplase: Pharmacodynamics and Pharmacokinetics. Dr Kevin Reiling. Tissue Plasminogen Activator. Coagulation Factors. Fibrinolysis. Plasminogen. Fibrinogen. Plasmin. Fibrin. Coagulation and Fibrinolysis. Natural Regulatory Balance.

★ ★ ★ ★ ★

856 views • 24 slides
Eugene Braunwald C. Michael Gibson Carolyn H. McCabe Tara Yoder

Eugene Braunwald C. Michael Gibson Carolyn H. McCabe Tara Yoder

TIMI 31 A Phase II, Open-Label, Multi-Center, Dose Escalation Study to Determine the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BB-10153 in ST Segment Elevation Myocardial Infarction. Eugene Braunwald C. Michael Gibson Carolyn H. McCabe Tara Yoder.

★ ★ ★ ★ ★

403 views • 22 slides

View Plasminogen activators PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Plasminogen activators PowerPoint presentations. You can view or download Plasminogen activators presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.